Category: CVD and disorders of other organs
-
-
A Physical Activity and Sitting Time Balance Index and All-Cause Mortality Risk
October 30, 2024Sitting Time Balance Index
-
-
32nd ESC 2024 Congress Coverage: Three Biomarkers and 30-Year Cardiovascular Outcomes in Women
October 13, 202432nd ESC 2024: Cardiovascular Outcomes in Women
-
31st ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (3)
October 13, 202431st ESC 2024: ESC 2024 CCS Guideline (3)
-
30th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (2)
October 12, 202430th ESC 2024: ESC 2024 CCS Guideline (2)
-
29th ESC 2024 Congress Coverage: Noise and Air Pollution as Risk Factors for Hypertension
October 12, 202429th ESC 2024: Noise and Air Pollution as RF for HTN
-
28th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (1)
October 12, 202428th ESC 2024: ESC 2024 CCS Guideline (1)
-
26th ESC 2024 Congress Coverage: Lowering of non–high-density lipoprotein cholesterol after Myocardial Infarction
October 9, 202426th ESC 2024: ILowering of non-HDL cholesterol after MI and prognosis
-
25th ESC 2024 Congress Coverage: ESC 2024 Guideline for Management of Peripheral Arterial and Aortic Diseases
October 9, 202425th ESC 2024: ESC 2024 PAAD Guideline
-
-
-
9th ESC 2024 Congress Coverage: BedMed and BedMed-Frail Trials
September 18, 20249th ESC 2024: BedMed and BedMed-Frail Trials
-
-
-
-
-
Daily Cardiology Symposium 1403: Nutrition and Exercise
July 17, 2024DCS 1403: Nutrition and Exercise
-
-
-
-
ACC.24 Congress Coverage: Superiority Trial of Enalapril to Prevent Anthracycline-induced Cardiotoxicity
May 7, 2024ACC.24: PROACT Trial
-
Save The Date: Hypertension and Hyperlipidemia Academy, No. 16
May 7, 2024Save The Date: 15th H&H Academy
-
ACC.24 Congress Coverage: Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease
April 17, 2024ACC.24: SGLT2i in ACHD
-
ACC.24 Congress Coverage: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
April 17, 2024ACC.24: Bridge TIMI 73a Trial
-
ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
April 16, 2024ACC.24: Semaglutide in HFpEF and DM
-
ACC.24 Congress Coverage: Mandibular Advancement Device vs CPAP in Obstructive Sleep Apnea
April 16, 2024ACC.24: MAD vs CPAP in OSA
-
Case Discussion 115 Answer: Hormonal Contraceptive Medications in Patients with Hypertension
April 6, 2024Case Discussion 115 Answer: OCPs in Hypertensive patients
-
Impact: Evaluation of a Best-Practice Advisory for Primary Aldosteronism Screening
April 6, 2024Impact: EHR tool for aldosteronism diagnosis
-
Impact: Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors
April 6, 2024Impact: Nitrates and PDE-5 inhibitors and Nitrates in CAD
-
Case Discussion 114 Answer: Cardiovascular considerations in patients receiving FLOT chemotherapy regimen
March 16, 2024Case Discussion 112 Answer: FLOT chemotherapy regimen and cardiovascular system
-
-
Case Discussion 113 Answer: Considerations before initiating antihypertensive treatment
January 30, 2024Case Discussion 113 Answer: Choosing the best antihypertensive agent
-
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy
January 16, 2024Case Discussion 109 Answer: GI protection in SAPT
-
-
-
-
-
AHA23 Congress Coverage: Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT trial
November 18, 2023HA23 Congress Coverage: BP control after hypertensive pregnancy (POP-HT)
-
AHA23 Congress Coverage: Daily Marijuana Use is Associated With Incident Heart Failure: “All of Us” Research Program
November 18, 2023AHA23 Congress Coverage: Daily Marijuana and HF ("All of Us Research Program")
-
AHA23 Congress Coverage: Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia: MINT trial
November 15, 2023AHA23 Congress Coverage: Blood Transfusion in MI and Anemia (MINT trial)
-
AHA23 Congress Coverage: Hypertension Treatment and Risk of Dementia
November 14, 2023AHA23 Congress Coverage: HTN and Dementia
-
Case Discussion 106: Approach to the diagnosis and management of asymptomatic hyperuricemia
November 13, 2023Case Discussion 102: asymptomatic hyperuricemia
-
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
September 17, 2023ESC 2023: New DM and CVD Guideline
-
-
-
-
-
-
-
-
The Lost Puzzle In Diabetes Treatment: CAD and PAD in Patients with Diabetes
August 21, 2023CAD and PAD in DM
-
-
-
-
-
-
Daily Cardiology Symposium 1402 Day 1 Panel 3
July 25, 2023Acute Coronary Syndrome and Acute Chest Pain
-
Daily Cardiology Symposium 1402 Day 1 Panel 1
July 25, 2023Cardiopulmonary resuscitation and Narrow-complex Tachyarrhythmia
-
-
-
-
-
-
-
-
Cardiac considerations and monitoring in patients receiving Acetylcholinesterase inhibitors
June 12, 2023Acetylcholinesterase inhibitors' cardiac considerations
-
-
-
-
-
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physician healthcare professionals
May 18, 2023H&H Academy: clinical tips for non-physicians
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Aminian
May 18, 2023YCA 1402 introduction by Dr. Aminian
-
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Shishehbor
May 13, 2023YCA 1402 introduction by Dr. Shishehbor
-
Impact: Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure
May 6, 2023Impact: Sacubitril/Valsartan and renal function in HF
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
-
Young Cardiologist Award 1402 Introduction video by A. Yahyavi, MD
April 29, 2023YCA 1402 introduction by Dr. Yahyavi
-
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
-
Impact: Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality
February 13, 2023Impact: Healthy Eating and mortality risk
-
Case Discussion 70: Potassium supplementation in mild to moderate Hypokalemia
January 21, 2023Case Discussion 70: Management of mild to moderate Hypokalemia
-
Case Discussion No. 68 Answer: anticoagulation in pregnancy
December 19, 2022Case Discussion No. 68 Answer
-
Impact: single chest x-ray could predict 10-year CVD risk
December 17, 2022Impact: one CXR to determine 10-yr CVD risk
-
-
Save the date: Cardiorenal Metabolic Crossroads, 5th session
September 13, 2022Save the date: Cardiorenal Metabolic Crossroads, 5th session
-
Save the date: Case-based discussion in patients with diabetes
August 30, 2022Save the date: Case-based discussion in patients with diabetes
-
-
-
-
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
Save the date: Hypertension and Hyperlipidemia Academy No. 10
August 18, 2022Save the date: H&H Academy No. 10
-
-
-
-
-
-
-
Save the date: 23rd case-based ECG interpretation workshop
June 30, 202223rd ECG workshop for medical and nursing trainees
-
-
Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD
June 26, 2022DCS 1401: Pharmacotherapy in CAD
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Save the date: Hypertension and Hyperlipidemia Academy, 8th
May 10, 2022Save the date: 8th H&H Academy
-
-
Save the date: 22nd case-based ECG interpretation workshop
May 7, 202222nd ECG workshop for medical and nursing trainees
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
-
-
-
Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening
March 11, 2022FH 1: diagnosis and screening
-
-
-
-
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
March 8, 2022Umbrella: HTN, diagnosis and management of HTN
-
Save the date: Hypertension and Hyperlipidemia Academy 7
March 3, 2022Save the date: the 7th H&H Academy session
-
-
-
-
-
-
-
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
January 18, 2022H&H Academy: nurses and assistants
-
Familial hypercholesterolemia, a narrative review, part 1: definition and burden
January 14, 2022FH 1: Definition and burden
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
At a Glance: Approach to Ticagrelor-induced Dyspnea
January 2, 2022Managing dyspnea induced by Ticagrelor
-
Save the date: 21st case-based ECG interpretation workshop
December 28, 202121st ECG workshop for medical and nursing trainees
-
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Save the date: Hypertension and hyperlipidemia academy, session 4
November 16, 2021The 4th session of Hypertension and hyperlipidemia academy
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Save the date: Cardiometabolic grand round, 5th session
November 8, 2021The 5th session of Cardiometabolic grand round program
-
Primary prevention in dyslipidemia as the only cardiovascular risk factor
November 4, 2021Dyslipidemia in primary prevention of low-risk patients
-
Late-breaking Science in Cardiovascular disease prevention
November 2, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
Management of dyslipidemia in diabetic patients
October 24, 2021DLP and T2DM: approach and management
-
DiaBeat: The Beating Heart of Diabetes (8th session)
October 19, 20218th Diabetes Masterclass for Cardiologists
-
Save the date: Late-breaking Science in Cardiovascular disease prevention
October 19, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
Save the date: 20th case-based ECG interpretation workshop
September 18, 202120th ECG workshop for medical and nursing trainees
-
-
The clinical landscape for Diabetes and Cardiovascular disease
August 24, 2021T2DM and cardiovascular diseases: The clinical landscape
-
-
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
August 14, 20217th Diabetes Masterclass for Cardiologists
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
-
Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD
August 1, 20217th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention
-
Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19
July 31, 2021thromboprophylaxis in COVID-19
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
Save the date: 19th case-based ECG interpretation workshop
July 24, 202119th ECG workshop for medical and nursing trainees
-
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
July 12, 2021The fifth episode of Cardio-Watch: cardiometabolic disorders
-
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
July 5, 2021Diagnosis and management of Iron deficiency in HF patients
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
June 20, 2021SGLT2Is and the prevention of cardiovascular complications in T2DM
-
DCS 1400: session 2, Diabetes for cardiologists
June 16, 2021The second panel of DCS 1400: diabetes for cardiologists
-
DCS 1400: session 1, HTN and DLP
June 16, 2021The first panel of DCS 1400: hypertension and dyslipidemia
-
-
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
June 13, 2021The Third episode of Cardio-Watch: AF
-
Save the date: Cardiometabolic Grand Round 4th session
June 1, 2021The fourth session of Cardiometabolic grand round
-
How to reduce the atherosclerotic cardiovascular risk
May 18, 2021A case-based Review on HTN and DLP management
-
Updates on the management of Diabetes and cardiometabolic disease
May 18, 2021Actoverco Diabetes Lunch Webinar
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
-
Impact: the paradox of physical activity in cardiovascular disease
May 2, 2021The contemporary Copenhagen general population study
-
DiaBeat: The Beating Heart of Diabetes (5th session)
May 1, 20215th Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: SGLT2 inhibition: Making waves in the heart failure landscape
December 31, 2020Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: Cardiometabolic Grand Round (2)
December 27, 2020A brief talk on DM medication challenges in patients with CVD
-
Impact: EMPA-RESPONSE-AHF
December 7, 2020Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)
December 2, 2020A quick review on the findings of TIPS-3 trial from AHA congress 2020
-
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
December 2, 2020The Important findings of SCORED trial from AHA 2020 congress in brief
-
High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)
December 2, 2020A quick review on the findings of INVESTED trial from AHA congress 2020
-
Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)
November 30, 2020The effects of Ticarelor+ASA in Acute Stroke
-
Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)
November 30, 2020Sotagliflozin in T2DM and exacerbated HF
-
Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)
November 26, 2020Iron supplementation in acute heart failure
-
Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)
November 3, 2020Finerenone protecting kidneys
-
Save the date: Cardiometabolic Grand Round
November 1, 2020A brief talk on DM management in patients with CVD
-
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
Save the date: VTE Prophylaxis in Patients with COVID-19
October 20, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
VTE Prophylaxis in Patients with COVID-19
October 19, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Smoking and the Heart the Struggle Continues
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
The weight of the world: The global challenge of obesity
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (17)
September 16, 2020Part Seventeen: Trial Review, REALITY
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (3)
September 16, 2020Part Three: Trial Review; THEMIS, PAD
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Impact: Colchicine in patients with acute coronary syndrome
September 1, 2020The findings of COPS trial
-
Impact: Colchicine in patients with chronic coronary syndrome
September 1, 2020The findings of LoDoCo2 trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
Save the date: Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Pharmacological approach to ACS management in patients on DOAC
August 12, 2020Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
-
Dosage Modification of DOACs in Different Clinical Scenarios & in Renal Impairment
July 3, 2020Algorithmic approach to DOACs Dose Adjustment in CKD
-
Save the date: Optimizing Heart Failure Care Throughout the Patient Journey
June 30, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
Optimizing Heart Failure Care Throughout the Patient Journey
June 25, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
-
CardioPoint (8): When to consider drug treatment in hypertension?
May 24, 2020A Brief Description on Practical Points in Cardiometabolic Field
-
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
Save the date: COVID and Cardiometabolic Challenges
April 3, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
-
Predicting the Risk of Post-stroke Atrial Cardiopathy
February 27, 2020An interim analysis from ACARDIA trial
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Intensive LDL lowering beyond current recommendations for MACE prevention
February 12, 2020A meta-analysis of RCTs
-
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
January 21, 2020The findings of a recent study
-
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
January 21, 2020A meta-analysis of RCTs
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Intensive Blood Pressure lowering and the Concerns about Falling
January 18, 2020The findings of SPRINT trial
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
November 29, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
Triglyceride Lowering and Cardiovascular Risk Reduction
November 4, 2019A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
-
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
August 24, 2019The findings of COMPASS trial
-
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
July 9, 2019Preventing the cardiotoxicity of Trastuzumab
-
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
May 29, 2019The findings of REASTART Trial
-
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
May 25, 2019DAPT after ischemic stroke or TIA
-
CardioPoint (1):Statins-Who is eligible?-Which dose?
May 19, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
-
